💡 在您使用本产品前请认真阅读说明书,这对您顺利完成实验很有帮助。
|
🏷️ 产品编码
RB9T37014519
|
🧬 中文名称
抗人IL-23 p19参考抗体
|
|
📝 英文名称
Anti-Human IL‑23 p19 Reference Antibody
| |
|
📦 形态
Liquid
|
🧪 纯度
>95% as determined by SDS-PAGE.
|
|
🔹 内毒素水平
Please contact with the lab for this information.
| |
|
🔬 应用
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
| |
|
🌍 种属
Human
|
🧫 表达系统
Mammalian Cells
|
|
🔢 登录号
Q9NPF7
|
🔹 宿主种属
Humanized
|
|
🔹 克隆性
Monoclonal
|
🔹 抗体亚型
IgG4-kappa
|
|
🔹 纯化方式
Protein A/G purified from cell culture supernatant.
|
🔹 浓度
1 mg/ml
|
|
🔹 种属反应性
Human
|
🔹 靶标
SGRF, IL-23-A, IL-23 subunit alpha, Interleukin-23 subunit p19, IL23A, Interleukin-23 subunit alpha, IL-23p19
|
|
🔹 背景信息
Mirikizumab (Eli Lilly and Company), Risankizumab (Boehringer Ingelheim and AbbVie), Tildrakizumab (Sun Pharma), Brazikumab (AstraZeneca), and Guselkumab (Janssen Biotech Inc.) are other drugs which target IL-23 and received the FDA approval for the treatment of psoriasis.
| |
|
🏷️ 别名
LY-3074828, 1884201-71-1
| |
🧴 储存缓冲液
0.01M PBS, pH 7.4.
❄️ 稳定性和储存
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
⚠️ For research use only. Not suitable for clinical or therapeutic use.